Table of Contents
Generics in Belgium industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Belgium generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
*For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
*The Belgian generics market is expected to generate total revenues of $596.6m in 2014, representing a compound annual growth rate (CAGR) of 4.4% between 2010 and 2014.
*Market consumption volume is forecast to increase with a CAGR of 4.5% between 2010 and 2014, to reach a total of 27.9% of total pharma volume in 2014.
*The performance of the market is forecast to decelerate, with an anticipated CAGR of 3% for the five-year period 2014 - 2019, which is expected to drive the market to a value of $690.7m by the end of 2019.
Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Belgium
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Belgium
Leading company profiles reveal details of key generics market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Belgium generics market with five year forecasts
Macroeconomic indicators provide insight into general trends within the Belgium economy
Key Questions Answered
What was the size of the Belgium generics market by value in 2014?
What will be the size of the Belgium generics market in 2019?
What factors are affecting the strength of competition in the Belgium generics market?
How has the market performed over the last five years?
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 Summary Systemic Lupus Erythematosus (SLE) is a systemic inflammatory autoimmune disease ...
PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of ...
PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...